Kristina Zint

1.3k total citations
37 papers, 796 citations indexed

About

Kristina Zint is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Internal Medicine. According to data from OpenAlex, Kristina Zint has authored 37 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 8 papers in Economics and Econometrics and 6 papers in Internal Medicine. Recurrent topics in Kristina Zint's work include Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Kristina Zint is often cited by papers focused on Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Kristina Zint collaborates with scholars based in United States, Germany and Netherlands. Kristina Zint's co-authors include Dorothee B. Bartels, Christine Teutsch, Jonathan L. Halperin, Menno V. Huisman, Sérgio Dubner, Kenneth J. Rothman, Gregory Y.H. Lip, Miney Paquette, Krista F. Huybrechts and Sebastian Schneeweiß and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kristina Zint

36 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristina Zint United States	13	667	285	104	87	54	37	796
Tomas Forslund Sweden	15	489 0.7×	176 0.6×	81 0.8×	131 1.5×	20 0.4×	35	656
Mariano de la Figuera Spain	14	540 0.8×	85 0.3×	52 0.5×	34 0.4×	41 0.8×	36	643
Supriya Shore United States	14	576 0.9×	142 0.5×	88 0.8×	44 0.5×	40 0.7×	54	845
Pil‐Sung Yang South Korea	11	472 0.7×	47 0.2×	80 0.8×	108 1.2×	19 0.4×	42	598
Meytal Avgil Tsadok Israel	15	675 1.0×	147 0.5×	42 0.4×	133 1.5×	6 0.1×	45	910
Miguel Camafort Spain	17	624 0.9×	42 0.1×	103 1.0×	83 1.0×	49 0.9×	124	918
Nemin Chen United States	8	198 0.3×	63 0.2×	42 0.4×	59 0.7×	25 0.5×	14	324
Tiffany Chang United States	8	341 0.5×	29 0.1×	26 0.3×	102 1.2×	32 0.6×	16	501
N Genès France	18	827 1.2×	44 0.2×	73 0.7×	48 0.6×	42 0.8×	34	1.0k
Manuel Anguita‐Sánchez Spain	14	462 0.7×	16 0.1×	21 0.2×	43 0.5×	139 2.6×	58	720

Countries citing papers authored by Kristina Zint

Since Specialization

Citations

This map shows the geographic impact of Kristina Zint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Zint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Zint more than expected).

Fields of papers citing papers by Kristina Zint

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Zint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Zint. The network helps show where Kristina Zint may publish in the future.

Co-authorship network of co-authors of Kristina Zint

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Zint. A scholar is included among the top collaborators of Kristina Zint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Zint. Kristina Zint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Shihai, Lionel Riou França, Gregory Y.H. Lip, et al.. (2022). Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program. PLoS ONE. 17(10). e0274237–e0274237. 5 indexed citations

Lip, Gregory Y.H., Christine Teutsch, Oskars Kalējs, et al.. (2021). Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. European Journal of Internal Medicine. 91. 75–80. 3 indexed citations

Teutsch, Christine, Sérgio Dubner, Hans‐Christoph Diener, et al.. (2021). Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF. SHILAP Revista de lepidopterología. 5(1). e35–e42. 2 indexed citations

Schellong, Sebastian, Walter Ageno, Kok Han Chee, et al.. (2021). Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Seminars in Thrombosis and Hemostasis. 48(4). 446–458. 26 indexed citations

Dubner, Sérgio, Christine Teutsch, Menno V. Huisman, et al.. (2020). Characteristics and 2-Year Outcomes of Dabigatran Treatment in Patients with Heart Failure and Atrial Fibrillation: GLORIA-AF. ESC Heart Failure. 7(5). 2679–2689. 5 indexed citations

Huybrechts, Krista F., Chandrasekar Gopalakrishnan, Dorothee B. Bartels, et al.. (2019). Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation. Clinical Pharmacology & Therapeutics. 107(6). 1405–1419. 12 indexed citations

Paquette, Miney, Lionel Riou França, Christine Teutsch, et al.. (2019). Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. The American Journal of Cardiology. 125(3). 383–391. 27 indexed citations

Gopalakrishnan, Chandrasekar, et al.. (2019). Evaluating utilization patterns of oral anticoagulants in routine care. Journal of Thrombosis and Haemostasis. 17(7). 1033–1043. 9 indexed citations

Mazurek, Michał, Christine Teutsch, Hans‐Christoph Diener, et al.. (2019). Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program. American Heart Journal. 218. 123–127. 21 indexed citations

10.

Huybrechts, Krista F., Chandrasekar Gopalakrishnan, Jessica M. Franklin, et al.. (2018). Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records. Clinical Pharmacology & Therapeutics. 105(4). 979–993. 16 indexed citations

11.

Mazurek, Michał, Menno V. Huisman, Kenneth J. Rothman, et al.. (2018). Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. The American Journal of Medicine. 131(8). 945–955.e3. 22 indexed citations

12.

Gopalakrishnan, Chandrasekar, et al.. (2017). Abstract 16498: Monitoring of Safety and Effectiveness of Dabigatran Relative to Warfarin in Routine Care. Circulation. 1 indexed citations

13.

Paquette, Miney, Lionel Riou França, Christine Teutsch, et al.. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 70(13). 1573–1583. 36 indexed citations

14.

Paquette, Miney, Menno V. Huisman, Gregory Y.H. Lip, et al.. (2017). PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 69(11). 374–374. 1 indexed citations

15.

Lip, G Y H, Dorothee B. Bartels, Albrecht Elsaesser, et al.. (2015). GLORIA-AF Investigators: Antithrombotic treatment patterns in 10,871 patients with newly diagnosed non-valvular atrial fibrillation: the GLORIA-AF Registry Program, Phase II. The American Journal of Medicine. 0–0. 1 indexed citations

16.

Halperin, Jonathan L., Menno V. Huisman, Hans‐Christoph Diener, et al.. (2015). ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II). Journal of the American College of Cardiology. 65(10). A1518–A1518. 2 indexed citations

17.

Bykov, Katsiaryna, Dorothee B. Bartels, Krista F. Huybrechts, et al.. (2015). Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thrombosis and Haemostasis. 114(12). 1277–1289. 103 indexed citations

18.

Seeger, John D., Dorothee B. Bartels, Krista F. Huybrechts, et al.. (2014). Abstract 16227: Safety and Effectiveness of Dabigatran Relative to Warfarin in Routine Care. Circulation. 130. 7 indexed citations

19.

Seeger, John D., Dorothee B. Bartels, Krista F. Huybrechts, et al.. (2013). Abstract 15187: Monitoring the Safety and Effectiveness of Dabigatran and Warfarin in Routine Care: An Interim Analysis Using U.S. Healthcare Utilization Data. Circulation. 128. 1 indexed citations

20.

Teutsch, Christine, Kristina Zint, Diana Ackermann, & Andreas Clemens. (2013). Design and rationale of GLORIA-AF: A Global Registry Program on Long- Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact